750 related articles for article (PubMed ID: 16410358)
1. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.
Zhang Y; Lee FY; Barrera G; Lee H; Vales C; Gonzalez FJ; Willson TM; Edwards PA
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1006-11. PubMed ID: 16410358
[TBL] [Abstract][Full Text] [Related]
2. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.
Cariou B; van Harmelen K; Duran-Sandoval D; van Dijk TH; Grefhorst A; Abdelkarim M; Caron S; Torpier G; Fruchart JC; Gonzalez FJ; Kuipers F; Staels B
J Biol Chem; 2006 Apr; 281(16):11039-49. PubMed ID: 16446356
[TBL] [Abstract][Full Text] [Related]
3. Regulation of carbohydrate metabolism by the farnesoid X receptor.
Stayrook KR; Bramlett KS; Savkur RS; Ficorilli J; Cook T; Christe ME; Michael LF; Burris TP
Endocrinology; 2005 Mar; 146(3):984-91. PubMed ID: 15564327
[TBL] [Abstract][Full Text] [Related]
4. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition.
Duran-Sandoval D; Cariou B; Percevault F; Hennuyer N; Grefhorst A; van Dijk TH; Gonzalez FJ; Fruchart JC; Kuipers F; Staels B
J Biol Chem; 2005 Aug; 280(33):29971-9. PubMed ID: 15899888
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor is essential for normal glucose homeostasis.
Ma K; Saha PK; Chan L; Moore DD
J Clin Invest; 2006 Apr; 116(4):1102-9. PubMed ID: 16557297
[TBL] [Abstract][Full Text] [Related]
6. Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist.
Zhao T; Wang J; He A; Wang S; Chen Y; Lu J; Lv J; Li S; Wang J; Qian M; Li H; Shen X
Metabolism; 2021 Jun; 119():154771. PubMed ID: 33831422
[TBL] [Abstract][Full Text] [Related]
7. Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
Han SY; Song HK; Cha JJ; Han JY; Kang YS; Cha DR
Acta Diabetol; 2021 Apr; 58(4):495-503. PubMed ID: 33399988
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
[TBL] [Abstract][Full Text] [Related]
9. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
[TBL] [Abstract][Full Text] [Related]
10. Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.
Ma Y; Huang Y; Yan L; Gao M; Liu D
Pharm Res; 2013 May; 30(5):1447-57. PubMed ID: 23371517
[TBL] [Abstract][Full Text] [Related]
11. Involvement of KLF11 in hepatic glucose metabolism in mice via suppressing of PEPCK-C expression.
Zhang H; Chen Q; Jiao T; Cui A; Sun X; Fang W; Xie L; Liu Y; Fang F; Chang Y
PLoS One; 2014; 9(2):e89552. PubMed ID: 24586865
[TBL] [Abstract][Full Text] [Related]
12. An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.
Xie C; Jiang C; Shi J; Gao X; Sun D; Sun L; Wang T; Takahashi S; Anitha M; Krausz KW; Patterson AD; Gonzalez FJ
Diabetes; 2017 Mar; 66(3):613-626. PubMed ID: 28223344
[TBL] [Abstract][Full Text] [Related]
13. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
[TBL] [Abstract][Full Text] [Related]
14. Effect of simvastatin on the expression of farnesoid X receptor in diabetic animal models of altered glucose homeostasis.
Wang L; Huang X; Hu S; Ma X; Wang S; Pang S
Chin Med J (Engl); 2014; 127(2):218-24. PubMed ID: 24438607
[TBL] [Abstract][Full Text] [Related]
15. Role of bile acids and bile acid receptors in metabolic regulation.
Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X receptor represses hepatic lipase gene expression.
Sirvent A; Verhoeven AJ; Jansen H; Kosykh V; Darteil RJ; Hum DW; Fruchart JC; Staels B
J Lipid Res; 2004 Nov; 45(11):2110-5. PubMed ID: 15342685
[TBL] [Abstract][Full Text] [Related]
17. Bile acid treatment and FXR agonism lower postprandial lipemia in mice.
Farr S; Stankovic B; Hoffman S; Masoudpoor H; Baker C; Taher J; Dean AE; Anakk S; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G682-G693. PubMed ID: 32003602
[TBL] [Abstract][Full Text] [Related]
18. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
[TBL] [Abstract][Full Text] [Related]
19. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
[TBL] [Abstract][Full Text] [Related]
20. Capsaicin Improves Glucose Tolerance and Insulin Sensitivity Through Modulation of the Gut Microbiota-Bile Acid-FXR Axis in Type 2 Diabetic db/db Mice.
Hui S; Liu Y; Chen M; Wang X; Lang H; Zhou M; Yi L; Mi M
Mol Nutr Food Res; 2019 Dec; 63(23):e1900608. PubMed ID: 31539192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
